[1]
M. Hasan, C. Wiedyaningsih, and N. M. Yasin, “Public Perspective on Hyperlipidemia Drugs and Sentiments About Hyperlipidemia on Twitter”, Borneo J Pharm, vol. 6, no. 3, pp. 330–338, Aug. 2023.